Login / Signup

Hypophosphatemia attenuates improvements in vitality after intravenous iron treatment in patients with inflammatory bowel disease.

J B BjornerN KennedyS LindgrenR F Pollock
Published in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2024)
Utility values improved significantly with intravenous iron treatment. Improvement in utility values was primarily driven by Vitality scores, which showed significantly greater improvement in the ferric derisomaltose arm. Smaller decreases in phosphate were associated with significantly higher Vitality scores, suggesting that quality of life improvement is attenuated by hypophosphatemia. The utility values can inform future cost-utility analysis.
Keyphrases
  • patients with inflammatory bowel disease
  • high dose
  • iron deficiency
  • low dose